Combination therapy of inhibitors of the epidermal growth factor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.
Goudar, R; Keir, S; Hjelmeland, M; Conrad, C; Traxler, P; Lane, H; Wang, XF; Bigner, DD; Friedman, HS; Rich, JN
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference Start Date
Conference End Date